Desirée Hao

机构：University of Calgary, Comprehensive Cancer Center Vienna · ORCID：0000-0003-1727-1205

发表论文 147 篇 · 总被引 2405 次 · h-index 29

代表论文

• SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer (2023 · Annals of Oncology · 被引 101)
• The association between neighborhood‐level income and cancer stage at diagnosis and survival in Alberta (2023 · Cancer · 被引 17)
• Durvalumab-Associated Pneumonitis in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Real-World Population Study (2023 · Current Oncology · 被引 8)
• Phase 4 Multinational Multicenter Retrospective and Prospective Real-World Study of Nivolumab in Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck (2023 · Cancers · 被引 8)
• Acceptability of automatic referrals to supportive and palliative care by patients living with advanced lung cancer: qualitative interviews and a co-design process (2024 · Research Involvement and Engagement · 被引 4)
• Is the Medical Oncology Workforce in Canada in Jeopardy? Findings from the Canadian Association of Medical Oncologists’ COVID-19 Impact Survey Series (2024 · Current Oncology · 被引 3)